ERBB2 and cancer: PR expression was not constant, the positive expression of case 1 (Fig. 2B) and case 4 reached 90%, the expression of case 2 and case 5 (Fig. 2C) was negative, and only approximately 10% of the cancer cells in case 3 were positive, while HER2 was negative in all the cases (Table 4).